Yes Zimbabwe, it’s happening! We are excited to announce that Zimbabwe was selected as one of the ten countries globally to roll out lenacapavir, a breakthrough development in the fight against HIV.
For decades, we’ve fought to turn the tide against this epidemic, and each day we get closer🌍
Through a partnership with U.S.-based @GileadSciences and @GlobalFund, we’re delivering lenacapavir, the 𝐟𝐢𝐫𝐬𝐭 twice-yearly HIV prevention medicine.
In a large-scale clinical trial more than 𝟗𝟗% 𝐨𝐟 𝐩𝐞𝐨𝐩𝐥𝐞 𝐨𝐧 𝐥𝐞𝐧𝐚𝐜𝐚𝐩𝐚𝐯𝐢𝐫 𝐫𝐞𝐦𝐚𝐢𝐧𝐞𝐝 𝐇𝐈𝐕 𝐧𝐞𝐠𝐚𝐭𝐢𝐯𝐞. While this has the potential to save millions of lives, here in Zimbabwe it represents a major step toward ending new infections.
But this is more than medicine—it advances us on a pathway to a safer, stronger, and healthier future!
🔵By focusing on pregnant and breastfeeding women, we’re protecting the next generation.
🔵By strengthening healthcare systems, we’re empowering Zimbabwe to lead its own fight against HIV.
🔵And by making lenacapavir more affordable and accessible, no one is left behind.
This is American leadership at its best: driving innovation, and building a world where children, mothers, and communities can thrive.
Together, we’re not just fighting HIV—we’re winning.